Aaron Schwanke, | |
2301 N Lake Dr, Milwaukee, WI 53211-4508 | |
(414) 585-1458 | |
Not Available |
Full Name | Aaron Schwanke |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2301 N Lake Dr, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437824216 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | S5200019602108 (Wisconsin) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Aaron Schwanke, 2301 N Lake Dr, Milwaukee, WI 53211-4508 Ph: () - | Aaron Schwanke, 2301 N Lake Dr, Milwaukee, WI 53211-4508 Ph: (414) 585-1458 |
News Archive
"You can think of Congress's efforts to pay for health reform as being a little bit like a battle to slay a many-headed Hydra," writes the New York Times' economic columnist, David Leonhardt.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.
The Cochrane Collaboration and John Wiley & Sons, Inc., the publisher of The Cochrane Library and Wiley Health Learning activities, today announced that they have extended their partnership by launching a new health professional development resource called Cochrane Learning.
A new paper in Biological Psychiatry reports that chronic cannabis users have reduced levels of an enzyme called fatty acid amide hydrolase (FAAH).
› Verified 8 days ago